Financials EKF Diagnostics Holdings plc

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Delayed London S.E. 09:16:26 10/09/2024 BST 5-day change 1st Jan Change
29.30 GBX +2.63% Intraday chart for EKF Diagnostics Holdings plc +5.02% -7.42%

Projected Income Statement: EKF Diagnostics Holdings plc

Forecast Balance Sheet: EKF Diagnostics Holdings plc

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 -10.4 -20.3 -19.6 -11.4 -3.63 -11 -17.4 -25.3
Change - -295.19% -196.55% -158.16% -131.84% -403.28% -258.18% -245.4%
Announcement Date 07/04/20 30/03/21 29/03/22 28/03/23 20/03/24 - - -
1GBP in Million
Estimates

Cash Flow Forecast: EKF Diagnostics Holdings plc

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 1.418 1.631 4.335 4.434 6.598 3.15 3 3.15
Change - 15.02% 165.79% 2.28% 48.8% -52.26% -4.76% 5%
Free Cash Flow (FCF) 1 - 12.18 5.903 3.86 -0.664 6.966 7.193 8.715
Change - - -51.53% -34.61% -117.2% -1,149.06% 3.27% 21.15%
Announcement Date 07/04/20 30/03/21 29/03/22 28/03/23 20/03/24 - - -
1GBP in Million
Estimates

Forecast Financial Ratios: EKF Diagnostics Holdings plc

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

         
EBITDA Margin (%) - 26.73% 39.1% 32.37% 22.37% 19.74% 21.44% 23.61% 26.39%
EBIT Margin (%) - 18.65% 28.16% 31.39% 18.18% 13.51% 12.82% 15.09% 18.75%
EBT Margin (%) - - 23.53% 26.19% -13.42% 4.05% 15.2% 18.39% 21.38%
Net margin (%) - - 17.03% 19.37% -15.16% 4.47% - - -
FCF margin (%) - - 18.66% 7.21% 5.79% -1.26% 12.78% 12.27% 13.71%
FCF / Net Income (%) - - 109.57% 37.24% -38.21% -28.23% - - -

Profitability

         
ROA 4.53% 4.04% 10.36% 12.62% 5.23% 3.61% - - -
ROE 16.56% 5.82% 15.24% 18.69% -11.31% 3.83% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - - - - - - - -
Debt / Free cash flow - - - - - - - - -

Capital Intensity

         
CAPEX / Current Assets (%) - 3.16% 2.5% 5.3% 6.65% 12.54% 5.78% 5.12% 4.95%
CAPEX / EBITDA (%) - 11.81% 6.39% 16.37% 29.75% 63.54% 26.95% 21.67% 18.77%
CAPEX / FCF (%) - - 13.39% 73.44% 114.87% -993.67% 45.22% 41.71% 36.14%

Items per share

         
Cash flow per share 1 - 0.0111 0.0301 0.0222 0.0212 0.0139 - - -
Change - - 170.44% -26.21% -4.59% -34.4% - - -
Dividend per Share 1 - 0.01 0.011 0.012 0.012 0.012 - - -
Change - - 10% 9.09% 0% 0% - - -
Book Value Per Share 1 - 0.154 0.17 0.206 0.1612 - 0.1512 0.1512 0.1528
Change - - 10.43% 21.18% -21.74% - - -0.02% 1.08%
EPS 1 - - 0.0242 0.0344 -0.0221 0.0052 - - -
Change - - - 42.15% -164.24% -123.53% - - -
Nbr of stocks (in thousands) - 454,093 454,993 463,931 454,931 453,731 453,731 453,731 453,731
Announcement Date - 07/04/20 30/03/21 29/03/22 28/03/23 20/03/24 - - -
1GBP
Estimates
2024 *2025 *
P/E ratio - -
PBR 1.89x 1.89x
EV / Sales 2.17x 1.91x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.2855GBP
Average target price
0.3333GBP
Spread / Average Target
+16.75%
Consensus
  1. Stock Market
  2. Equities
  3. EKF Stock
  4. Financials EKF Diagnostics Holdings plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW